Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Werness

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Transactions of the American Clinical and Climatological Association|January 1, 1983
Hydroxyapatite--the forgotten crystal in calcium urolithiasisL H Smith, P G Werness
Kidney International|June 1, 1984
Calcium oxalate dihydrate formation in urineX Martin, L H Smith, P G Werness
Investigative Urology|November 1, 1979
Calcium oxalate dihydrate crystal growthP G Werness, S C Duckworth, L H Smith
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Metabolic and clinical disturbances in patients with calcium urolithiasisL H Smith, P G Werness, D M Wilson
The Journal of Laboratory and Clinical Medicine|February 1, 1982
Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolitesP G Werness, J H Bergert, L H Smith
Clinical Science (London, England : 1979)|October 1, 1981
Urinary crystal growth: effect of inhibitor mixturesP G Werness, J H Bergert, K E Lee
The Journal of Urology|December 1, 1985
Inhibitors of crystal growth of hydroxyapatite: a constant composition approachJ W Wilson, P G Werness, L H Smith
The Journal of Urology|October 1, 1984
Pentosan polysulfate as an inhibitor of calcium oxalate crystal growthX Martin, P G Werness, J H Bergert, et al.
The Journal of Urology|December 1, 1985
EQUIL2: a BASIC computer program for the calculation of urinary saturationP G Werness, C M Brown, L H Smith, et al.
Biochemistry|March 11, 1986
Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteinsR W Romberg, P G Werness, B L Riggs, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Transactions of the American Clinical and Climatological Association|January 1, 1983
Hydroxyapatite--the forgotten crystal in calcium urolithiasisL H Smith, P G Werness
Kidney International|June 1, 1984
Calcium oxalate dihydrate formation in urineX Martin, L H Smith, P G Werness
Investigative Urology|November 1, 1979
Calcium oxalate dihydrate crystal growthP G Werness, S C Duckworth, L H Smith
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Metabolic and clinical disturbances in patients with calcium urolithiasisL H Smith, P G Werness, D M Wilson
The Journal of Laboratory and Clinical Medicine|February 1, 1982
Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolitesP G Werness, J H Bergert, L H Smith
Clinical Science (London, England : 1979)|October 1, 1981
Urinary crystal growth: effect of inhibitor mixturesP G Werness, J H Bergert, K E Lee
The Journal of Urology|December 1, 1985
Inhibitors of crystal growth of hydroxyapatite: a constant composition approachJ W Wilson, P G Werness, L H Smith
The Journal of Urology|October 1, 1984
Pentosan polysulfate as an inhibitor of calcium oxalate crystal growthX Martin, P G Werness, J H Bergert, et al.
The Journal of Urology|December 1, 1985
EQUIL2: a BASIC computer program for the calculation of urinary saturationP G Werness, C M Brown, L H Smith, et al.
Biochemistry|March 11, 1986
Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteinsR W Romberg, P G Werness, B L Riggs, et al.
Pageof 3